{"Name":"DepoMed","perma":"depomed","BasicInfo":{"funded":"1995-01-01","isClosed":false,"closed":null,"short":"Depomed is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other."},"FundingRounds":[{"funding_type":"post_ipo_debt","series":null,"announcedDate":"2015-03-13","moneyRaised":575000000},{"funding_type":"convertible_note","series":null,"announcedDate":"2014-09-04","moneyRaised":300000000}],"Acquisitions":[],"AcquiredBy":null,"IPO":{"exchange":"NASDAQ","symbol":"DEPO","shares":1200000,"date":"1997-11-05","openPrice":6,"moneyRaised":7200000,"valuation":null},"Investments":[],"Products":[],"CurrentTeam":[{"title":"President and CEO","started":null,"ended":null,"firstName":null,"lastName":null}],"PastTeam":[{"title":"Senior Quality Roles","started":null,"ended":null,"firstName":"Steven","lastName":"Drake"},{"title":"Director","started":"2003-01-01","ended":"2005-01-01","firstName":"Mike","lastName":"Callaghan"}]}
